Defence Therapeutics Inc. (DTC) Grants 7.0M Performance RSUs; Board Change
Defence Therapeutics granted 7,000,000 performance-based RSUs to its CEO and Executive Chairman and moved Dr. Svetlana Selivanova from the Board to the Scientific Advisory Board to support radiopharma programs.Material DetailsContext by AI AnalystThis extends the company’s recently stated strategic…